Enhanced external counterpulsation creates acute blood flow patterns responsible for improved flow-mediated dilation in humans.
about
Enhanced external counterpulsation improves endothelial function and exercise capacity in patients with ischaemic left ventricular dysfunction.Enhanced external counterpulsation reduces indices of central blood pressure and myocardial oxygen demand in patients with left ventricular dysfunction.Exercise intensity modulates brachial artery retrograde blood flow and shear rate during leg cycling in hypoxia.The role of enhanced external counter pulsation therapy in clinical practice.Acute impact of retrograde shear rate on brachial and superficial femoral artery flow-mediated dilation in humans.A single bout of whole-leg, peristaltic pulse external pneumatic compression upregulates PGC-1α mRNA and endothelial nitric oxide sythase protein in human skeletal muscle tissue.Internal validation of an automated system for brachial and femoral flow mediated dilation.Enhanced external counterpulsation improves peripheral resistance artery blood flow in patients with coronary artery disease.Angina and Its Management.Enhanced external counterpulsation (EECP) improves biomarkers of glycemic control in patients with non-insulin-dependent type II diabetes mellitus for up to 3 months following treatment.Enhanced external counterpulsation (EECP) decreases advanced glycation end products and proinflammatory cytokines in patients with non-insulin-dependent type II diabetes mellitus for up to 6 months following treatment.Peripheral conduit and resistance artery function are improved following a single, 1-h bout of peristaltic pulse external pneumatic compression.Peripheral resistance artery blood flow in subjects with abnormal glucose tolerance is improved following enhanced external counterpulsation therapy.
P2860
Q34415807-EA487A59-23D2-4B9B-A83B-BE3C4AC34452Q35235894-3AABFAA0-72A7-4AC8-AA33-D4341068B5C3Q35877550-BB613F43-E739-4A9F-9E5D-7A2CC2B29F03Q37568448-75CDE7A7-3201-4427-888F-42671CF7D53AQ37668427-DAFCF3F2-07A1-48EC-A268-6F5CD8E393F9Q39005765-141DB48E-6D6F-437B-AFF2-FA91B6B4D234Q41501342-4C7A74F3-D725-445E-8D9E-36386F61CEE4Q44459205-96C72C63-2DA5-4150-B1FF-D2E72A4307E6Q45300561-2C77BB1B-6597-4891-B89B-1694E1B0A3A8Q51284596-62185954-35E0-4336-880A-7BA595116110Q51712877-BECC1832-F038-4245-B6C5-0CEFEA05EDEFQ53842812-3E3AFCF5-D9E6-4FEF-93CA-2623705E4A7AQ54276416-0BAED3AF-689D-48E9-B29C-4933FC4EF85E
P2860
Enhanced external counterpulsation creates acute blood flow patterns responsible for improved flow-mediated dilation in humans.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Enhanced external counterpulsa ...... w-mediated dilation in humans.
@en
Enhanced external counterpulsa ...... w-mediated dilation in humans.
@nl
type
label
Enhanced external counterpulsa ...... w-mediated dilation in humans.
@en
Enhanced external counterpulsa ...... w-mediated dilation in humans.
@nl
prefLabel
Enhanced external counterpulsa ...... w-mediated dilation in humans.
@en
Enhanced external counterpulsa ...... w-mediated dilation in humans.
@nl
P2860
P356
P1476
Enhanced external counterpulsa ...... ow-mediated dilation in humans
@en
P2093
Randy W Braith
P2860
P2888
P304
P356
10.1038/HR.2012.169
P577
2012-10-18T00:00:00Z
P5875
P6179
1039660680